secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001437749-24-029206
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma reports judge invalidated Tagrisso patents; Wyeth appeals Sept 12
----------------------------------------------------------------------

- Jury awarded $107.5M for past infringement of '314 and '162 patents through Dec 2023.
- Judge granted AstraZeneca's motion, ruling patents invalid for lack of enablement/written description.
- Wyeth filed notice of appeal on Sept 12, 2024, challenging the invalidity ruling and other adverse orders.
- Puma was dismissed as plaintiff but retains contractual rights to recover damages under Pfizer agreement.
- Puma respectfully disagrees with the invalidity ruling; post-trial motions for supplemental damages and ongoing royalties pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924029206/0001437749-24-029206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924029206/pbyi20240913_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-029206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer